Geode Capital Management LLC Buys 24,596 Shares of Apyx Medical Co. (NASDAQ:APYX)

Geode Capital Management LLC lifted its position in Apyx Medical Co. (NASDAQ:APYX) by 7.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 352,809 shares of the company’s stock after purchasing an additional 24,596 shares during the quarter. Geode Capital Management LLC owned 0.94% of Apyx Medical worth $558,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Kingsview Wealth Management LLC lifted its holdings in Apyx Medical by 8.7% during the 4th quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company’s stock valued at $214,000 after purchasing an additional 10,800 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Apyx Medical during the fourth quarter valued at approximately $134,000. Commonwealth Equity Services LLC raised its position in Apyx Medical by 3.0% in the 4th quarter. Commonwealth Equity Services LLC now owns 527,061 shares of the company’s stock worth $833,000 after purchasing an additional 15,500 shares during the last quarter. Finally, Royce & Associates LP raised its position in Apyx Medical by 1.3% in the 4th quarter. Royce & Associates LP now owns 2,615,369 shares of the company’s stock worth $4,132,000 after purchasing an additional 32,879 shares during the last quarter. Institutional investors own 55.33% of the company’s stock.

Apyx Medical Stock Up 16.8 %

NASDAQ APYX opened at $1.25 on Friday. The stock has a fifty day moving average of $1.10 and a 200-day moving average of $1.34. The stock has a market capitalization of $47.24 million, a P/E ratio of -1.51 and a beta of 0.92. Apyx Medical Co. has a 52 week low of $0.76 and a 52 week high of $1.99. The company has a debt-to-equity ratio of 3.03, a quick ratio of 4.52 and a current ratio of 5.46.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings results on Thursday, March 13th. The company reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.01. The company had revenue of $14.22 million for the quarter, compared to the consensus estimate of $13.39 million. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. On average, equities research analysts forecast that Apyx Medical Co. will post -0.68 EPS for the current year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.